United States Enzymes Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     United States Enzymes 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " U n i t e d  S t a t e s  E n z y m e s  M a r k e t :  
I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 - 2 0 3 2 , "  t h e  U n i t e d  
S t a t e s  e n z y m e s  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  g r o w t h  r a t e  ( C A G R )  o f  7 . 0 0 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
E n z y m e s  a r e  b i o c a t a l y s t s  t h a t  a c c e l e r a t e  c h e m i c a l  r e a c t i o n s  w i t h i n  l i v i n g  o r g a n i s m s  b y  
Report l o w e r i n g  t h e  a c t i v a t i o n  e n e r g y  r e q u i r e d  f o r  t h e  r e a c t i o n s  t o  o c c u r .  T h e y  a r e  t y p i c a l l y  p r o t e i n s  
w i t h  s p e c i f i c  s h a p e s  t h a t  e n a b l e  t h e m  t o  i n t e r a c t  w i t h  s u b s t r a t e s ,  f a c i l i t a t i n g  t h e  c o n v e r s i o n  
o f  t h e s e  s u b s t r a t e s  i n t o  p r o d u c t s .  E n z y m e s  a r e  c r u c i a l  f o r  v a r i o u s  p h y s i o l o g i c a l  p r o c e s s e s  i n  
Highlight and o r g a n i s m s ,  i n c l u d i n g  d i g e s t i o n ,  m e t a b o l i s m ,  a n d  c e l l u l a r  f u n c t i o n s .  
T h e y  p l a y  a  v i t a l  r o l e  i n  i n d u s t r i e s  s u c h  a s  f o o d  a n d  b e v e r a g e ,  p h a r m a c e u t i c a l s ,  a g r i c u l t u r e ,  
a n d  t e x t i l e s ,  w h e r e  t h e y  a r e  u t i l i z e d  f o r  t h e i r  a b i l i t y  t o  c a t a l y z e  r e a c t i o n s  e f f i c i e n t l y  u n d e r  
Description m i l d  c o n d i t i o n s .  E n z y m e s  a r e  c l a s s i f i e d  b a s e d  o n  t h e  t y p e  o f  r e a c t i o n  t h e y  c a t a l y z e  a n d  a r e  
n a m e d  a c c o r d i n g l y ,  s u c h  a s  p r o t e a s e s  f o r  p r o t e i n  h y d r o l y s i s ,  a m y l a s e s  f o r  c a r b o h y d r a t e  
h y d r o l y s i s ,  a n d  l i p a s e s  f o r  l i p i d  h y d r o l y s i s .  W i t h  t h e i r  r e m a r k a b l e  s p e c i f i c i t y  a n d  e f f i c i e n c y ,  
e n z y m e s  o f f e r  n u m e r o u s  b e n e f i t s  i n  i n d u s t r i a l  a p p l i c a t i o n s ,  i n c l u d i n g  i m p r o v e d  p r o c e s s  
e f f i c i e n c y ,  r e d u c e d  e n e r g y  c o n s u m p t i o n ,  a n d  e n v i r o n m e n t a l l y  f r i e n d l y  p r o d u c t i o n  m e t h o d s .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - e n z y m e s - m a r k e t / r e q u e s t s a m p l e
Report Description
Uni t ed  S t a t es  Enzy mes  M ark e t  T rend s :
The  U n i t ed  S t a t es  e nzym es  m ar k e t  i s  w i t nes s ing  r ob us t  g r ow t h  d r i ve n  by  t he  i nc r e as ing  a war en ess  am ong  consu m er s  
r ega r d ing  t h e  bene f i t s  o f  enzy m e- base d  p r oduc t s  i n  va r i ous  i ndu s t r i e s ,  in c lud in g  f ood  and  bev e r age ,  h ea l t hc a r e ,  an d  
de t e r gen t s .  Enzym es  o f f e r  nu m er o us  advan t age s ,  su ch  as  im pr oved  p r od uc t  qua l i t y ,  enh ance d  e f f i c i ency ,  an d  
sus t a inab i l i t y ,  d r i v i ng  t he i r  adop t i on  ac r o ss  d i ve r se  app l i c a t i ons .  Se cond ly ,  t h e  g r o w ing  f ocu s  on  hea l t h  and  we l l ness  
am o ng  co nsum er s  i s  d r i v i ng  t h e  de m and  f o r  e nzym e  sup p lem en t s  and  f unc t i o na l  f oo ds  f o r m u la t ed  w i t h  d i ges t i v e  enz ym es  
t o  s uppo r t  ga s t r o in t es t in a l  he a l t h  a nd  i m pr o ve  nu t r i en t  ab so r p t i on .  
M or e ove r ,  ad vance m en t s  i n  enz ym e  eng i nee r in g  an d  b i o t ech no logy  have  l ed  t o  t he  d eve lop m en t  o f  n ove l  e nzym e  
f o r m u la t i o ns  w i t h  e nhan ced  s t ab i l i t y ,  spec i f i c i t y ,  a nd  a c t i v i t y ,  expa nd ing  t he i r  a pp l i cab i l i t y  i n  i ndus t r i a l  p r oce sse s  an d  
hea l t h ca r e  p r oduc t s .  Add i t i ona l l y ,  t he  r i s i ng  p r eva lence  o f  ch r on i c  d i s ease s ,  su ch  a s  d ig es t i ve  d i s o r de r s  and  m e t abo l i c  
synd r om es ,  i s  d r i v i ng  t h e  dem and  f o r  en zym e- ba sed  t he r apeu t i cs  and  d ia gnos t i c  assa ys  f o r  d i se ase  m a nage m en t  an d  
m on i t o r i ng .  Fu r t he r m or e ,  s t r i ng en t  r egu la t o r y  s t an da r d s  and  env i r o nm e n t a l  c once r ns  a r e  p r om p t ing  i nd us t r ie s  t o  adop t  
enzym e- ba sed  so lu t i ons  t o  ac h ieve  sus t a inab i l i t y  g oa l s  and  m in im iz e  en v i r onm en t a l  im pac t .
Vi ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / un i t ed - s t a t es - en zym es- m arke t
Type Insights:
• Protease
• Carbohydrase
• Lipase
• Polymerase and Nuclease
• Others
Report Source Insights:
• Microorganisms
Segmentation • Plants
• Animals
Reaction Type Insights:
• Hydrolase
• Oxidoreductase
• Transferase
• Lyase
• Others
Application Insights:
• Food and Beverages
• Household Care
• Bioenergy
Report • Pharmaceut ical  and Biotechnology
Segmentation • Feed
• Others
Regional Insights:
• Northeast
• Midwest
• South
• West
• AB Enzymes (ABF Ingredients)
• Advanced Enzyme Technologies Limited
• BASF SE
• Kerry Group plc
Competitive 
• Koninkl i jke DSM N.V.
Landscape • Novozymes A/S
with Key 
Players
How has the United States enzymes market 
performed so far and how will it perform in the 
coming years?
What has been the impact of COVID-19 on the 
United States enzymes market?
Key 
Questions What is the breakup of the United States enzymes market on the basis of type?
Answered in 
What is the breakup of the United States enzymes 
the Report market on the basis of source?
What is the breakup of the United States enzymes 
market on the basis of reaction type?
What is the breakup of the United States enzymes 
market on the basis of application?
What are the various stages in the value chain of 
the United States enzymes market?
What are the key driving factors and challenges in 
the United States enzymes?
Key 
Questions What is the structure of the United States enzymes market and who are the key players?
Answered in 
What is the degree of competition in the United 
the Report States enzymes market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    U n i t e d  S t a t e s  E n z y m e s  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    U n i t e d  S t a t e s  E n z y m e s  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    U n i t e d  S t a t e s  E n z y m e s  M a r k e t  -  B r e a k u p  b y  T y p e
    6 . 1     P r o t e a s e
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     C a r b o h y d r a s e
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )  
       
    6 . 3     L i p a s e
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 4     P o l y m e r a s e  a n d  N u c l e a s e
        6 . 4 . 1  O v e r v i e w
        6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 5     O t h e r s
        6 . 5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
Table of 7    U n i t e d  S t a t e s  E n z y m e s  M a r k e t  -  B r e a k u p  b y  S o u r c e    7 . 1     M i c r o o r g a n i s m s
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Contents         7 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2     P l a n t s
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 3     A n i m a l s
        7 . 3 . 1  O v e r v i e w
        7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
8    U n i t e d  S t a t e s  E n z y m e s  M a r k e t  -  B r e a k u p  b y  R e a c t i o n  T y p e
    8 . 1     H y d r o l a s e
        8 . 1 . 1  O v e r v i e w
        8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / u n i t e d - s t a t e s - en z y m e s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: